Dual expression of lambda genes in the MOPC-315 plasmacytoma

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Multiple expression of light chain RNAs is common in B-lymphocyte lineage cells, including myelomas.
• Typically, only one complete, functional light chain is translated per cell, despite the presence of multiple RNA transcripts.
• The MOPC-315 myeloma synthesizes an antibody with alpha heavy and lambda II light chains, with rearranged lambda genes and potentially absent or fragmented kappa genes.

Purpose of the Study:

• To investigate the presence of non-alpha and non-lambda II immunoglobulin-related proteins in MOPC-315 cells.
• To characterize the messenger RNA (mRNA) molecules present in MOPC-315 tumor cells.
• To identify and analyze molecular cDNA clones derived from MOPC-315 mRNA.

Main Methods:

• Derivation of molecular cDNA clones from MOPC-315 tumor cell mRNA.
• Analysis of cDNA clones to identify mRNA species.
• Nucleotide sequencing of identified mRNA species to determine their structure and origin.

Main Results:

• Identification of two distinct lambda chain mRNA species in MOPC-315 cells.
• One species corresponds to a normal lambda II light chain.
• The second species directs the synthesis of a deleted form of a lambda I protein, resulting from a specific sequence joining event.

Conclusions:

• MOPC-315 cells express two types of lambda light chain mRNA, one normal and one deleted.
• The deleted lambda I mRNA arises from a joining event between the variable and constant region coding sequences.
• This finding provides insights into the complex regulation of immunoglobulin light chain gene expression in B-lymphocytes.